IDYA
Price
$41.16
Change
+$1.22 (+3.05%)
Updated
Sep 2, 10:48 AM (EDT)
Capitalization
3.85B
69 days until earnings call
Intraday BUY SELL Signals
VOR
Price
$22.64
Change
+$0.16 (+0.71%)
Updated
Sep 1 closing price
Capitalization
1.34B
70 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IDYA vs VOR

IDYA vs VOR Comparison Chart in %
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Nektar Therapeutics (NASDAQ:NKTR), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Inovio Pharmaceuticals (NASDAQ:INO), Cel-Sci Corp (ASE:CVM).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.3B. The market cap for tickers in the group ranges from 58 to 138.81B. VRTX holds the highest valuation in this group at 138.81B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was -4%. For the same Industry, the average monthly price growth was 9%, and the average quarterly price growth was 2,388%. CELU experienced the highest price growth at 133%, while VBIO experienced the biggest fall at -97%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -21%. For the same stocks of the Industry, the average monthly volume growth was -10% and the average quarterly volume growth was -39%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 78
Price Growth Rating: 52
SMR Rating: 94
Profit Risk Rating: 92
Seasonality Score: -10 (-100 ... +100)

Market Cap

The average market capitalization across the group is 2.6B. The market cap for tickers in the group ranges from 1.34B to 3.85B. IDYA holds the highest valuation in this group at 3.85B. The lowest valued company is VOR at 1.34B.

High and low price notable news

The average weekly price growth across all stocks in the group was -6%. For the same group, the average monthly price growth was 10%, and the average quarterly price growth was 38%. VOR experienced the highest price growth at -6%, while IDYA experienced the biggest fall at -6%.

Volume

The average weekly volume growth across all stocks in the group was -45%. For the same stocks of the group, the average monthly volume growth was -10% and the average quarterly volume growth was -42%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 29
P/E Growth Rating: 74
Price Growth Rating: 38
SMR Rating: 97
Profit Risk Rating: 84
Seasonality Score: 50 (-100 ... +100)
VS
IDYA vs. VOR commentary
Sep 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Buy and VOR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 02, 2026
Stock price -- (IDYA: $39.95 vs. VOR: $22.64)
Brand notoriety: IDYA and VOR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 70% vs. VOR: 52%
Market capitalization -- IDYA: $3.85B vs. VOR: $1.34B
IDYA [@Biotechnology] is valued at $3.85B. VOR’s [@Biotechnology] market capitalization is $1.34B. The market cap for tickers in the [@Biotechnology] industry ranges from $138.81B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 1 FA rating(s) are green whileVOR’s FA Score has 1 green FA rating(s).

  • IDYA’s FA Score: 1 green, 4 red.
  • VOR’s FA Score: 1 green, 4 red.
According to our system of comparison, VOR is a better buy in the long-term than IDYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 4 TA indicator(s) are bullish while VOR’s TA Score has 3 bullish TA indicator(s).

  • IDYA’s TA Score: 4 bullish, 4 bearish.
  • VOR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, IDYA is a better buy in the short-term than VOR.

Price Growth

IDYA (@Biotechnology) experienced а -5.96% price change this week, while VOR (@Biotechnology) price change was -5.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.57%. For the same industry, the average monthly price growth was +9.27%, and the average quarterly price growth was +2351.37%.

Reported Earning Dates

IDYA is expected to report earnings on Nov 10, 2026.

VOR is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-2.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($3.85B) has a higher market cap than VOR($1.34B). VOR YTD gains are higher at: 73.089 vs. IDYA (15.563). IDYA has higher annual earnings (EBITDA): -178.86M vs. VOR (-371.42M). IDYA has more cash in the bank: 671M vs. VOR (492M). VOR has less debt than IDYA: VOR (2.94M) vs IDYA (28.6M). IDYA has higher revenues than VOR: IDYA (225M) vs VOR (0).
IDYAVORIDYA / VOR
Capitalization3.85B1.34B287%
EBITDA-178.86M-371.42M48%
Gain YTD15.56373.08921%
P/E RatioN/A0.13-
Revenue225M0-
Total Cash671M492M136%
Total Debt28.6M2.94M973%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
32
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
PROFIT vs RISK RATING
1..100
68
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IDYAVOR
RSI
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 9 days ago
74%
Bullish Trend 15 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
IDYA
Daily Signal:
Gain/Loss:
VOR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RNP20.150.02
+0.10%
Cohen & Steers REIT and Preferred and Income Fund
FCVCX19.00N/A
N/A
Fidelity Advisor Small Cap Value C
TIAGX18.32N/A
N/A
Timothy Plan Small/Mid Cap Growth Cl I
TPISX15.98N/A
N/A
Nuveen Quant Intl Small Cap Eq Premier
AILCX18.92-0.21
-1.10%
American Beacon International Eq C